Bioactive Compounds
-
B6688 GR 113808Summary: 5-HT4 receptor antagonist -
BA2776 GSK2256098Summary: A selective focal adhesion kinase (FAK) inhibitor that suppresses the growth and migration of pancreatic cancer cells -
C3697 N-Hydroxysulfosuccinimide (sodium salt)Summary: A non-cleavable linker used for antibody-drug conjugate (ADC) synthesis. -
BA9456 DL-O-TyrosineSummary: A tyrosine derivative. -
C8171 DigitoxoseSummary: Digitoxose (D-(+)-Digitoxose), a natural product that specifically and competitively inhibits glucose-stimulated insulin release from pancreatic islets in lean and obese mice. -
BA4118 FT895Summary: FT895 is a potent and selective inhibitor. -
A8777 Cy5 carboxylic acid(Et)Summary: Cy5 carboxylic acid (sulfonated, Et derivative, sodium salt), labels primary amines after EDC/NHS activation. -
C6430 Tannic acidSummary: A polyphenolic compound for the treatment of diarrhea, hemostasis, and skin inflammation -
B7851 Phenyl-benzothiazoleSummary: Benzothiazole-class biopharmaceutical intermediate, used for research on cellular regulatory mechanisms. -
B1744 Epinastine HClTarget: Histamine H1 ReceptorsSummary: Histamine receptor antagonist

